Introduction {#cesec10}
============

Although adults comprise more than half the total population of sub-Saharan Africa, they have been neglected in both the provision of health services and health-related research in Africa.[@bib1] Adults are crucial to ensure the survival of children[@bib2] and to drive economic development. The available published literature describing the burden of disease in adults in sub-Saharan Africa reports high amounts of uncertainty in the estimates, mainly as a result of weak or absent disease surveillance combined with the absence of vital registration in most of the region.[@bib3] Although focused surveys have estimated the burden of specific diseases, such as HIV and malaria,[@bib4; @bib5] these estimates do not provide a comprehensive description of the causes of poor health in the communities studied.

African populations are undergoing a demographic and epidemiological transition because of increased survival of children into adulthood,[@bib6] changes in the burden of infectious diseases such as malaria,[@bib7] and an increase in the risk factors for, and prevalence of, non-communicable diseases.[@bib8; @bib9] During this transition, data to guide public health policy on the continent are greatly needed.[@bib10] Available estimates of disease burden in sub-Saharan Africa rely heavily on modelling assumptions, which are questionable in the absence of adequate primary data.[@bib11] Although the use of verbal autopsy studies to establish community causes of death is increasing, and the techniques involved are improving,[@bib12] such studies do not have the diagnostic accuracy that hospitals can provide, and they do not include non-fatal causes of ill health.

Few published studies have used hospital-based data, and those that have done so have several limitations: they rarely use universally accepted coding systems and case definitions for the illnesses described;[@bib13] data capture is seldom complete because of various logistical challenges in the use of electronic medical systems;[@bib14] they do not usually report age-stratified incidence rates because of the absence of denominator data, which makes it impossible to distinguish changes in disease burden over time from changes in population structure;[@bib15] and they do not take into account the fact that admission rates fall with increasing distance from hospital, which leads to underestimation of the true disease burden in the population.[@bib16] Finally, although the disability-adjusted life-year (DALY) has been suggested as the appropriate metric for measurement of disease burden, few studies beyond the Global Burden of Disease (GBD) project have reported DALYs for sub-Saharan Africa.

In this analysis, we used linked hospital and population surveillance data to establish the inpatient burden and range of disease in adults in a rural coastal district in Kenya, and simultaneously describe the effect of distance from hospital on admission rates.

Methods {#cesec20}
=======

Study setting and participants {#cesec30}
------------------------------

Kilifi District (now part of Kilifi County) is located on the Indian Ocean coast of Kenya. It is a poor, rural area and the population mainly relies on subsistence farming. The Kilifi Health and Demographic Surveillance System (KHDSS) covers roughly 40% of Kilifi District, along a coastal strip 35 km north and south of Kilifi town ([figure 1](#fig1){ref-type="fig"}). The KHDSS records births, deaths, and migration events in a population of 260 000 people, living in an area 891 km^2^ in size.[@bib17] The age and sex structure of the population differs substantially within the KHDSS area, with fewer adult men in the more rural regions than in the semi-urban regions because of selective outmigration of this group to nearby towns in search of paid employment. Since 2000, the KHDSS area has been mapped and updated with global positioning system receivers (Magellan Navigation Inc, Santa Clara, CA, USA) to define the coordinates of all homesteads and the vector paths of the roads in the area. Roughly 33% of all adult deaths in KHDSS occur at Kilifi District Hospital,[@bib18] and the overall mortality rates do not differ substantially with varying distance from the hospital ([appendix p 3](#sec1){ref-type="sec"}).

Within the KHDSS area, the total fertility rate (4·73), crude birth rate (34·7 per 1000 person-years of observation), population growth rate (2·79% per year), and proportion of the population younger than 15 years (49%) are similar to the rates across Kenya. However, the under 5-mortality ratio (41 per 1000 livebirths) and HIV prevalence (4·9% in antenatal clinic attendees) are lower than the Kenyan national averages (74 per 1000 births and 8·0%, respectively).[@bib19]

Kilifi District Hospital is situated at the centre of the KHDSS area and the main route of access to the hospital is the Mombasa-Malindi road ([figure 1](#fig1){ref-type="fig"}). The hospital serves as a first-level referral hospital that provides care to both adults and children in Kilifi District. The hospital provides an acute 24-h daily medical admission service run by a medical team of more than 40 staff that includes four consultants, ten medical and clinical officers, nurses, and support staff. The Kenya Ministry of Health classifies the hospital as a level IV hospital, with the highest level hospitals in Kenya classified as level VI.[@bib20]

Medical care at Kilifi District Hospital is provided according to national and WHO guidelines.[@bib21] Laboratory facilities available at the hospital include basic haematological and biochemical tests and advanced microbiological culture facilities. Imaging facilities include ultrasound and radiographs. As a minimum, all admitted patients undergo a full blood count and an HIV antibody test in keeping with the Kenya Ministry of Health opt-out policy on HIV testing.[@bib22] Patients meeting criteria for possible invasive bacterial disease or meningitis are investigated with blood and cerebrospinal fluid cultures. Other tests, such as urea and electrolyte tests, liver function tests, arterial blood gas measurement, radiographs, and ultrasound imaging, are done depending on clinical indication. Patients who need more advanced testing, such as CT scans and histopathological examination, are transported to facilities in Mombasa, 60 km south of Kilifi.

A prospective surveillance of adult inpatients was initiated in January, 2007 to investigate the indirect effects on adult disease of the introduction of pneumococcal conjugate vaccine in children. This surveillance was started by the KEMRI-Wellcome Trust Research Programme, with funding from GAVI via the PneumoADIP (Pneumococcal vaccines Accelerated Development and Introduction Plan). The key elements of the surveillance were the standardisation of clinical investigations to follow Kenya Ministry of Health guidelines,[@bib21] the introduction of real-time electronic medical records, and the linking of hospital admissions to the population register of the KHDSS. On admission to hospital, patients are interviewed by ward clerks to establish whether they reside within the KHDSS and to find their unique identity within the population register. This unique personal identification is then linked to all clinical, laboratory, and demographic data. Admission, diagnostic, and discharge data are entered directly into a standardised electronic medical record with Filemaker version 11 software. At discharge, medical staff list up to two discharge diagnoses for each patient, on the basis of all clinical, radiological, and laboratory data available. Weekly clinical meetings for all cadres of staff are held as part of continuous medical education to standardise diagnostic procedures and medical care. Monthly audits are done to analyse the quality of data collected and to give feedback to the clinical team to maintain consistency and quality.

Procedures and statistical analysis {#cesec40}
-----------------------------------

We used Stata version 11.2 to analyse data for all adult patients (aged ≥15 years) admitted to the hospital from Jan 1, 2007, to Dec 31, 2012. All discharge diagnoses were assigned three-character codes from the International Classification of Diseases (ICD) tenth revision (ICD-10). Because of the large number of individual diagnoses, we grouped them according to ICD chapters[@bib23] to compute admission rates. We calculated the proportions of admissions and of deaths due to all illnesses categorised by ICD chapter in adults presenting to Kilifi District Hospital. Admissions of pregnant women for labour and delivery were excluded; however admissions with pregnancy-related disorders, such as first-trimester abortion and post-partum sepsis, were included.

We divided the KHDSS area into seven strata with respect to distance from Kilifi District Hospital ([figure 1](#fig1){ref-type="fig"}). Each stratum represented an incremental distance of 5 km. We calculated distance to the hospital as the sum of the shortest distance from each homestead to the Mombasa-Malindi road and the distance along the road to the hospital. Rates of hospital admission, with allowance for several admissions, were calculated for KHDSS residents living within each distance stratum. We assumed that people living in the nearest distance stratum (within 5 km of the hospital) had perfect geographical access to the hospital (ie, the best access compared with everyone else in the surveillance area) and therefore the rates here would be least susceptible to distance-related bias. We used person-years based on exact periods of residence within the KHDSS as denominators to compute rates. All rates were directly age-standardised with use of the INDEPTH standard population structure for sub-Saharan Africa.[@bib24] To compare admission rates for ICD categories by distance, we used Poisson regression to calculate incidence rate ratios.

Measurement of disability-adjusted life-years {#cesec50}
---------------------------------------------

For each of the 15 leading discharge diagnoses of patients admitted to Kilifi District Hospital, we estimated the number of DALYs lost. We calculated DALYs with open-access templates from WHO.[@bib25] We used age-specific person-years of observation obtained from the KHDSS as denominators in incidence calculations. For the purposes of this analysis, we grouped all HIV-related illnesses (ICD-10 codes B20--B24), and diabetes-related illnesses (ICD-10 codes E10--E14) into single categories. We assumed that repeated admissions of patients with HIV or diabetes were attributable to the same underlying illness and therefore we limited the incidence calculation to the first admission episode for such patients. In calculations of the incidence of disorders that are viewed as part of the range of HIV disease (eg, gastroenteritis, meningitis, pneumonia, and cervical cancer), we excluded patients with HIV infection.

In keeping with the latest GBD methods, we did not discount future values (ie, life-years gained in the future) and no age weights were used.[@bib26] Life expectancy was set at 86 years for both men and women in agreement with new methods that use the lowest age-specific death rates recorded across countries in 2010.[@bib27] We used recently updated weights from the GBD project[@bib28] to apply disability weighting. We searched for published reports describing average survival of patients with the diseases of interest in similar settings in sub-Saharan Africa and entered these for the years lived with disability component of the DALY calculations.[@bib29; @bib30; @bib31; @bib32; @bib33; @bib34; @bib35; @bib36] For chronic illnesses (eg, asthma), for which no data were available for estimation of life expectancy after first diagnosis in similar settings, we used the difference between mean age at diagnosis and the overall KHDSS life expectancy figures[@bib17] to compute the years lived with disability.

All clinical data for this analysis were gathered as part of routine care; therefore, individual patient consent was not needed. Community consent was obtained for collection of demographic surveillance data. The analysis was approved by the Ethical Review Committee of the Kenya Medical Research Institute.

Role of the funding source {#cesec60}
--------------------------

The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.

Results {#cesec70}
=======

After exclusion of pregnant women admitted for delivery, there were 18 712 adult patient admissions to Kilifi District Hospital between Jan 1, 2007, and Dec 31, 2012, of which 10 536 (56%) were women and 8176 (44%) were residents of the KHDSS. During the same period, there were 790 635 person-years of observation in adult residents of the KHDSS. Outcome data were available for 18 418 (98%) patients, of whom 1899 (10·3%) died. Median length of hospital stay was 73 h (IQR 38--178 h). In the patients who died in hospital, the median time to death was 112 h (IQR 40--279 h); 334 (17·6%) of these 1899 patients died within 24 h of admission.

[Figure 2](#fig2){ref-type="fig"} shows the causes of admission and death by ICD category. Accidents and injuries accounted for the highest number (1625) of admissions in men, whereas infectious diseases (2597) were the most frequent cause of admission in women. Case-fatality rates were highest for nervous system disorders (26%) and circulatory system illnesses (23%). Infectious and parasitic diseases, dominated by HIV-related illnesses, accounted for 39% of all hospital deaths, most of which occurred in patients younger than 55 years of age. Circulatory system illnesses, mainly stroke and heart failure, were the second most common cause of death, and accounted for 16% of all deaths in hospital.

All reported rates of hospital admissions are age-standardised. [Table 1](#tbl1){ref-type="table"} shows admission rates for each ICD category of disorders for people living in the stratum nearest to (within 5 km of) the hospital and for the entire KHDSS area. The all-cause hospital admission rates for people living within 5 km of Kilifi District Hospital were 1446 (95% CI 1297--1603) admissions per 100 000 person-years for women and 991 (861--1137) for men. Women were admitted to hospital at a significantly higher rate than were men (incidence rate ratio \[IRR\] 1·4, 95% CI 1·3--1·6; p\<0·0001). Rates of hospital admission for women were highest for infectious and parasitic diseases, pregnancy-related disorders, and circulatory disorders ([table 1](#tbl1){ref-type="table"}), with the rate of admission for infectious diseases for women roughly double that for men (IRR 1·8, 95% CI 1·5--2·1; p\<0·0001). In men, rates of hospital admission were highest for infectious and parasitic diseases, injuries, and digestive system illnesses ([table 1](#tbl1){ref-type="table"}). The rate of hospital admission for injuries was substantially higher for men than for women (IRR 1·9, 95% CI 1·4--2·5; p\<0·0001). Rates of hospital admission for circulatory disorders did not vary significantly by sex (IRR 1·2, 95% CI 0·9--1·6; p=0·098). [Table 2](#tbl2){ref-type="table"} shows age-specific admission rates for different disease categories for the distance stratum closest to the hospital, and [appendix p 12](#sec1){ref-type="sec"} shows these rates for the entire KHDSS surveillance area. [Appendix pp 13--17](#sec1){ref-type="sec"} shows rates of hospital admissions for each ICD code for the distance stratum closest to the hospital.

Admission rates for KHDSS residents in all ICD categories decreased with increasing distance from their place of residence to the hospital ([table 1](#tbl1){ref-type="table"} and [figure 3](#fig3){ref-type="fig"}). For men, the all-cause admission rate fell by 11% (95% CI 7--14) and for women it fell by 20% (17--23) for every 5 km increase in distance from the hospital. In men, admission rates decreased most sharply for neoplasms (30% decrease \[95% CI 9--45\] per 5 km increase in distance). In women, admission rates declined most sharply for endocrine disorders (35% per 5km increase in distance, 95% CI 22--46; [table 1](#tbl1){ref-type="table"}. Distance decay curves for each illness category are available in [appendix pp 4--11](#sec1){ref-type="sec"}.

[Table 3](#tbl3){ref-type="table"} shows the DALYs lost in the population living in the distance stratum closest to the hospital. The highest number of DALYs lost were attributable to HIV-related illnesses (2050 DALYs lost per 100 000 person-years of observation). Non-communicable diseases and injuries accounted for 741 DALYs lost per 100 000 person-years of observation. Although pregnancy-related disorders accounted for a high number of admissions in women ([figure 2](#fig2){ref-type="fig"}) and were the second most common cause of admission ([table 1](#tbl1){ref-type="table"}), they ranked 13th in the causes of DALYs lost. Meningitis not associated with HIV infection accounted for few hospital admissions, but because of its high case-fatality rate and high residual disability, it was a leading cause of DALYs lost. For all 15 illnesses listed in [table 3](#tbl3){ref-type="table"}, most of the DALYs lost were due to years of life lost rather than years of life lived with disability. DALYs lost for the whole KHDSS area are shown in [appendix p 18](#sec1){ref-type="sec"}.

Discussion {#cesec80}
==========

Insufficient data about disease burden have been acknowledged as a major barrier to public health decision making in Africa.[@bib37] We have used linked clinical and demographic surveillance to comprehensively describe the burden of disease in adults admitted to hospital in Kilifi, Kenya, and we have investigated the extent to which access to hospital care can bias the use of hospital data to estimate the morbidity and mortality in the community. The population in Kilifi is undergoing an epidemiological transition[@bib38] that is typical of rural and semi-urban populations in sub-Saharan Africa.

A major strength of our analysis is the use of robust clinical and demographic data collected prospectively over a 6-year period by a dedicated and consistent team of clinical scientists. We improved the quality of both the care provided and the data collected by holding regular audits with feedback on performance. Linking of clinical surveillance to population data also enabled us to calculate the incidence of disease in adults, unlike most hospital-based studies from Africa, which do not have population denominator data.[@bib13]

An absence of denominator data, and other deficiencies of hospital-based studies ([panel](#box1){ref-type="boxed-text"}), has led scientists to describe cause-specific deaths largely using verbal autopsy. In this technique, family members or caregivers of deceased patients are interviewed about the circumstances of death after the event with use of standardised questionnaires and the data are analysed by use of probabilistic models.[@bib12] The potential for misclassification in verbal-autopsy-based studies has contributed to controversies regarding the burden of adult mortality, such as that attributable to malaria.[@bib39] In settings where clinicians have access to high-quality clinical, laboratory, and imaging investigations, physician-coded hospital data are superior to verbal autopsy data.[@bib18]

The computation of DALYs lost in this setting emphasises the importance of diseases, such as diabetes, which generate a high DALY burden despite the fact that they rank lower in the causes of hospital admission than do other illnesses ([table 1](#tbl1){ref-type="table"}). The GBD project has published summary figures of DALYs for the whole eastern region of sub-Saharan Africa.[@bib26] Our estimate of DALYs lost because of HIV is nearly double the GBD estimate for eastern sub-Saharan Africa, despite the fact that HIV prevalence in Kilifi (4·9% in antenatal clinic attendees[@bib40]) is lower than the regional average, which ranges from 8 to 12%.[@bib41] By contrast, the number of DALYs lost to stroke and diabetes was slightly lower in our estimate than in the GBD regional estimate. The fact that our data are from one hospital means they have low generalisability, but the methods used here show the opportunity to extend the geographic representation of disease burden data by capitalising on existing centres of population surveillance. In the past two decades, substantial investment has been made in demographic surveillance systems in Africa within the INDEPTH network.[@bib42] What this study shows is the added value of the integration of data based on demographic surveillance systems with good-quality local morbidity surveillance.

In Kilifi, HIV-related diseases accounted for a large proportion of hospital admissions and of DALYs lost. The high case-fatality rates reported suggest that many patients presented with advanced disease. Late presentation to care has also been recorded in South Africa.[@bib43] Although progress has been made in Africa in reducing incident HIV infections,[@bib44] the people who do become infected in Kilifi are still not being enrolled sufficiently early into HIV care.[@bib45]

Another important finding in this study is the comparatively high burden of non-communicable diseases and injuries in Kilifi. Injuries accounted for the highest number of admissions in men, and the rate of hospital admission for injuries was second only to that of infectious diseases. Complications of diabetes were the third leading cause of DALYs lost, followed by stroke---an unusual finding for a rural population in a developing nation. Studies of diabetes and stroke in Africa have generally shown a higher burden of these diseases in urban areas.[@bib46; @bib47] Women lost more DALYs to stroke than did men, largely because stroke occurred at an earlier age in women (mean 60 years of age) than in men (mean 65 years of age). As with HIV, most of the lost DALYs attributable to diabetes and stroke were because of premature death, rather than years of life lived with disability. Stroke, HIV-related illnesses, and diabetes all need well-functioning chronic care systems that are not yet available in most of sub-Saharan Africa.[@bib9]

The data presented in our analysis are probably a substantial under-representation of the true burden of disease in the region because presentation rates decline notably with distance from hospital ([figure 3](#fig3){ref-type="fig"}). We minimised this bias by limiting incidence calculations to the distance stratum closest to the hospital. Although the analysis of distance decline by disease classification ([appendix](#sec1){ref-type="sec"}) has finite precision, in general, the effect of distance on presentation rates was greater for non-communicable than communicable diseases and was greatest for neoplastic and endocrine disorders. Apart from distance, other possible causes of disease underascertainment with use of hospital data are hospital user fees[@bib48] and presentation to traditional healers, which was beyond the scope of this study.

Because of insufficient diagnostic facilities at the hospital, some illness categories might have been underdiagnosed, especially rare malignancies. However, this would not have affected data for common cancers, such as cervical cancer, since adequate facilities were available to diagnose these diseases.

In conclusion, this analysis shows that the integration of clinical and demographic surveillance can be used to measure the burden of disease in adults at discrete centres in sub-Saharan Africa. The main problem with this form of surveillance is the degree of underascertainment attributable to living at a distance from hospital. We have described the magnitude and disease-specific pattern of this bias and the methods we used to minimise it.

We found that the main causes of morbidity in adults in coastal Kenya were HIV-related disease, pregnancy-related disorders, non-communicable diseases, and injuries. In view of the strong existing investment in demographic surveillance systems across Africa, our study depicts a model to investigate disease patterns in diverse settings across the continent that could be used to guide public health policy and stimulate appropriate research.
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======================
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![Location of the Kilifi Health and Demographic Surveillance System](gr1){#fig1}

![Number of admissions and inpatient deaths at Kilifi District Hospital by ICD category and sex, 2007--12\
Length of bars indicate total number of admissions; red bars indicate number of deaths. Numerical labels on bars indicate case-fatality rate (%). The total number of admissions was 18 418, with 1899 deaths. ICD=International Classification of Diseases.](gr2){#fig2}

![Age-standardised admission rates by distance from Kilifi District Hospital\
(A) Women. (B) Men. PYO=person-years of observation](gr3){#fig3}

###### 

Age-standardised admission rates by ICD category of disorders and incidence rate ratios per 5 km increase in distance from Kilifi District Hospital

                                                              **Women**           **Men**                                                                 
  ----------------------------------------------------------- ------------------- ---------------- ------------------- ----------------- ---------------- -------------------
  Blood disorders                                             42 (19--75)         21 (19--23)      0·90 (0·77--1·05)   50 (23--88)       13 (11--15)      0·82 (0·66--1·01)
  Circulatory system                                          105 (69--155)       28 (25--30)      0·87 (0·78--0·97)   87 (51--137)      34 (30--37)      0·93 (0·83--1·05)
  Digestive system                                            70 (40--111)        16 (14--18)      0·78 (0·65--0·93)   112 (70--166)     44 (40--48)      0·88 (0·79--0·99)
  Endocrine disorders                                         103 (66--150)       17 (15--19)      0·65 (0·54--0·78)   67 (37--113)      18 (15--20)      0·89 (0·75--1·04)
  Genitourinary system                                        83 (49--126)        23 (20--25)      0·79 (0·68--0·91)   76 (44--125)      39 (35--43)      0·94 (0·83--1·07)
  Infectious and parasitic                                    303 (237--380)      72 (67--76)      0·76 (0·71--0·82)   169 (117--235)    52 (47--56)      0·83 (0·75--0·93)
  Accidents and injuries                                      79 (63--98)         24 (21--26)      0·84 (0·73--0·96)   135 (113--160)    79 (73--84)      0·97 (0·89--1·06)
  Mental and behavioural disorders                            44 (22--80)         10 (8--12)       0·76 (0·60--0·95)   37 (16--76)       10 (8--11)       0·76 (0·57--1·01)
  Musculoskeletal system                                      16 (4--41)          3 (1--3)         0·68 (0·44--1·06)   11 (1--34)        4 (2--4)         0·76 (0·49--1·18)
  Neoplasms                                                   111 (72--160)       25 (21--27)      0·72 (0·62--0·84)   43 (19--82)       11 (8--12)       0·70 (0·55--0·91)
  Nervous system                                              24 (9--53)          10 (8--11)       0·91 (0·75--1·12)   35 (13--69)       13 (10--15)      0·88 (0·70--1·10)
  Poisoning                                                   10 (2--35)          3 (2--4)         0·81 (0·56--1·18)   7 (1--34)         3 (2--4)         0·86 (0·59--1·25)
  Pregnancy-related disorders                                 239 (180--306)      62 (57--65)      0·81 (0·75--0·88)   NA                NA               NA
  Respiratory system                                          69 (40--111)        20 (18--22)      0·78 (0·67--0·91)   52 (26--95)       18 (15--20)      0·83 (0·69--1·00)
  Skin and subcutaneous tissue                                11 (2--35)          4 (2--4)         0·83 (0·59--1·18)   14 (2--42)        3 (2--4)         0·77 (0·51--1·17)
  Symptoms and signs not classified elsewhere                 93 (59--141)        21 (18--23)      0·77 (0·67--0·89)   79 (44--125)      25 (22--28)      0·91 (0·80--1·05)
  All hospital admissions[†](#tbl1fn2){ref-type="table-fn"}   1446 (1297--1603)   785 (770--799)   0·80 (0·77--0·83)   991 (861--1137)   668 (652--683)   0·89 (0·86--0·93)

Rates and 95% CIs are per 100 000 person-years of observation among residents. ICD=International Classification of Diseases. KHDSS=Kilifi Health and Demographic Surveillance System. NA=not applicable.

Incidence rate ratios are per 5 km increase in distance from Kilifi District Hospital.

Admission rate attributable to all causes includes diagnoses that were not assigned an ICD code.

###### 

Age-specific rates of hospital admission for KHDSS residents living within 5 km of Kilifi District Hospital, by ICD category and age group

                                                **Women**        **Men**                                                                                                
  --------------------------------------------- ---------------- ---------------- ---------------- ----------------- ---------------- ---------------- ---------------- ------------------
  Blood disorders                               62 (41--90)      32 (13--66)      120 (48--248)    0 (0)             42 (24--69)      46 (21--88)      134 (49--292)    382 (46--1379)
  Circulatory system                            20 (9--38)       96 (60--147)     498 (333--715)   827 (303--1800)   16 (6--35)       51 (25--94)      312 (171--524)   1337 (537--2754)
  Digestive system                              115 (86--151)    110 (71--164)    69 (19--176)     0 (0)             61 (39--92)      185 (130--256)   379 (221--608)   191 (5--1064)
  Endocrine disorders                           35 (20--58)      119 (78--175)    429 (278--633)   689 (224--1608)   40 (22--66)      62 (32--108)     335 (187--552)   0 (0)
  Genitourinary system                          111 (82--146)    170 (120--234)   86 (28--200)     138 (3--768)      32 (16--56)      62 (32--108)     335 (187--552)   573 (118--1674)
  Infectious and parasitic                      297 (249--351)   657 (554--774)   532 (362--755)   413 (85--1208)    165 (126--211)   334 (258--426)   357 (204--580)   191 (5--1064)
  Accidents and injuries                        60 (39--87)      133 (89--191)    172 (82--316)    0 (0)             170 (131--217)   206 (147--280)   268 (138--468)   0 (0)
  Mental and behavioural disorders              78 (54--108)     74 (42--119)     17 (0--96)       0 (0)             72 (47--104)     57 (28--101)     22 (1--124)      0 (0)
  Musculoskeletal system                        7 (1--19)        55 (28--96)      34 (4--124       0 (0)             27 (13--49)      0 (0)            22 (1--124)      0 (0)
  Neoplasms                                     82 (58--113)     221 (163--292)   275 (157--446)   276 (33--996)     16 (6--35)       41 (18--81)      156 (63--322)    191 (5--1064)
  Nervous system                                22 (11--41)      37 (16--72)      34 (4--124)      276 (33--996)     29 (15--52)      41 (18--81)      112 (36--260)    0 (0)
  Poisoning                                     20 (9--38)       14 (3--40)       0 (0)            0 (0)             16 (6--35)       10 (1--37)       0 (0)            0 (0)
  Pregnancy-related disorders                   547 (481--620)   303 (235--386)   34 (4--124)      0 (0)             NA               NA               NA               NA
  Respiratory system                            58 (38--84)      83 (49--131)     223 (119--382)   413 (85--1208)    37 (20--62)      57 (28--101)     112 (36--260)    382 (46--1379)
  Skin and subcutaneous tissue                  58 (38--84)      138 (93--197)    257 (144--425)   827 (303--1800)   45 (26--72)      92 (55--146)     290 (155--496)   382 (46--1379)
  Symptoms and signs not classified elsewhere   4 (1--16)        28 (10--60)      34 (4--124)      928 (479--1621)   5 (1--19)        5 (0--29)        89 (24--229)     0 (0)

Data are rate of hospital admission (95% CI). Rates and 95% CIs are per 100 000 person-years of observation in the KHDSS. Person-years of observation were as follows: 15--34 years: 45 152 (women). 37 668 (men); 35--54 years: 21 764 (women), 19 463 (men); 55--74 years: 5826 (women), 4480 (men); ≥75 years: 726 (women), 524 (men). KHDSS=Kilifi Health and Demographic Surveillance System. NA=not applicable.

###### 

Disability-adjusted life-years lost for the 15 leading causes of admission to Kilifi District Hospital in residents living within 5 km of the hospital

                                 **Women**   **Men**   **Disability-adjusted life-years lost**        
  ------------------------------ ----------- --------- ----------------------------------------- ---- ------
  HIV                            2170        114       1713                                      60   2050
  Meningitis                     375         28        349                                       14   385
  Diabetes                       262         91        321                                       56   364
  Stroke                         130         13        183                                       11   166
  Pneumonia                      195         10        95                                        4    156
  Gastroenteritis                141         1         183                                       1    161
  Heart failure                  97          6         20                                        8    68
  Benign prostatic hypertrophy   0           0         63                                        0    63
  Asthma                         0           65        0                                         51   59
  Cervical cancer                0           10        0                                         0    10
  Head injury                    0           3         0                                         8    5
  Spontaneous abortion           0           4         0                                         0    4
  Peptic ulcer disease           0           3         0                                         1    2
  Inguinal hernia                0           0         0                                         1    0·3
  Fractures                      0           0         0                                         0    0·03

Years of life lost, years lived with disability, and disability-adjusted life-years lost are per 100 000 person-years of observation.

###### Research in context

**Systematic review**

We have previously done a systematic review assessing data from studies of adults admitted to hospital in sub-Saharan Africa.[@bib13] The main finding was that the few studies available were done poorly, thus casting doubt as to the quality of burden of disease estimates for Africa. Additionally, in December, 2012, the publication of the latest findings from the Global Burden of Disease project by the Institute of Health Metrics stimulated substantial controversy, mainly as a result of insufficient primary data.[@bib11] The part of the world with the poorest quality of primary disease burden data is sub-Saharan Africa, where vital registration covers less than 5% of deaths.[@bib3]

**Interpretation**

In this Article, we report a rich seam of primary data from adults in Kilifi, Kenya, and show how disease burden data could be obtained at many representative points in Africa through the integration of clinical surveillance into existing investments in demographic surveillance systems. In 2007, we linked adult hospital-based morbidity surveillance into the Kilifi Demographic Surveillance System to establish the major causes of hospital admission and death. We have calculated disease rates using accurate population denominators, and estimated disability-adjusted life-years lost because of leading causes of illness. The results show the dual burden of infectious and non-communicable disease faced by adults in sub-Saharan Africa. Additionally, we have characterised the effect of geographical access to care, which is the main bias in the use of hospital-based data to estimate disease incidence. The public health significance of our study is that it shows that a few additional investments in existing health and demographic surveillance systems can fill the information gap for cause-specific morbidity and mortality in African adults. Such data are essential to populate models of disease burden for the management of health planning in Africa in the next decade.
